SR One Capital Management
Jill is a Partner with SR One based on the East Coast. Jill’s educational background is in biochemistry and her career has spanned 20 years in various facets of the biotechnology industry. Initially, she spent time in strategy consulting focusing on commercial projects with pharma, then migrated to operating roles in corporate development, particularly at Dynavax Technologies (DVAX), where she completed multiple pharma partnerships and private and public financings. Jill started her investing career at SR One in 2011 and has been involved in marquee investments including Alios Biopharma, Progyny (PGNY) and Principia Biopharma (PRNB), among others.
This person is not in any teams
This person is not in any offices
SR One Capital Management
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies.